Longport, Inc. Share Price

Equities

LPTI

US5431371039

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 07:00:00 26/04/2024 pm IST 5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for Longport, Inc. 0.00% 0.00%
Sales 2003 500K 41.73M Sales 2004 2.46M 205M Capitalization 23.89M 1.99B
Net income 2003 - 0 Net income 2004 - 0 EV / Sales 2003 6.28 x
Net Debt 2003 10.98K 916K Net cash position 2004 1.17M 97.18M EV / Sales 2004 9.24 x
P/E ratio 2003
-3.33 x
P/E ratio 2004
-36 x
Employees -
Yield 2003 *
-
Yield 2004
-
Free-Float 86.64%
More Fundamentals * Assessed data
Dynamic Chart
3 years
0.00
Extreme 0
0.00
5 years
0.00
Extreme 0
0.01
10 years
0.00
Extreme 0
0.04
More quotes
Date Price Change Volume

Delayed Quote OTC Markets, April 26, 2024 at 07:00 pm IST

More quotes
Longport, Inc. develops, manufactures, markets and sells ultrasound imaging systems. The Company focuses on high resolution medical ultrasound. The Company focuses on providing imaging systems that help in the prevention, assessment and treatment of medical conditions. The Company offers a high-resolution ultrasound (HRUS) imaging system, EPISCAN I-200, which utilizes ultrasound to image the skin and underlying soft tissue. EPISCAN I-200 can be connected to a range of interchangeable imaging probes that enable the imaging of the skin and underlying soft tissue at frequencies between 20 megahertz (MHz) and 50 MHz. EPISCAN is utilized in a range of clinical applications, as well as in research and development. EPISCAN enables the examination of tissue at a microscopic level. Its technology is used in a range of applications, such as wound assessment and prevention, dermatology, aesthetics, and research, including validation of processes and products that impact the skin.
More about the company